Catalog IDs: OP-101-1003, OP-101-1004
The TruSight Tumor 170 RUO kit consists of library preparation reagents to convert sample nucleic acids to sequenceable libraries. The TruSight Tumor 170 kit also contains the associated TruSight Tumor 170 software. The assay begins with DNA and/or RNA extracted from FFPE tissue as the input sample type. The variant calling algorithms are provided in the TruSight Tumor 170 App. The TruSight Tumor 170 App reports mutations (single nucleotide variants, multinucleotide variants, indels, copy number variants, splice variants, and gene fusions) in full coding regions of the targeted genes.